Biopharma

We partner with biopharma teams to quantify novel tumor properties and deploy AI imaging biomarkers to improve clinical trials.

Our insights drive faster, smarter clinical development by enabling:

• Optimized patient stratification
• Early OS signal
• Longitudinal monitoring of treatment effect 
• Retrospective analyses

All without additional tissue, esoteric testing methods, or large data sets.

Our AI imaging features have been demonstrated in over eighty publications. Unlike "black box" AI, our imaging biomarkers are interpretable, mechanism-aligned, and effective even in small datasets, such as  Phase 1 clinical trials.